Alpha Compute ALP
NASDAQ ALP
$4.28 -1.13 (-20.95%)
As of: Sep 10, 2026 · 12:40 PM EDT

Alpha Compute (ALP) Revenue (2009 - 2025)

Alpha Compute's (ALP) quarterly Revenue came in at $3.2 million in Q4 2025, up 59.55% quarter-over-quarter from $2.0 million in Q4 2022.

Analysis

Alpha Compute (ALP) Revenue (2009 - 2025) Analysis & Trends

Alpha Compute (ALP) has reported Revenue for 4 consecutive years, with $3.2 million the latest figure, recorded in Q4 2025.

  • On a quarterly basis, Revenue changed N/A year-over-year to $3.2 million in Q4 2025; TTM through Dec 2025 was $7.7 million, a N/A change from a year earlier, with the FY2026 full-year figure at $97000.0, changed N/A from the prior year.
  • Revenue was $3.2 million for Q4 2025 at Alpha Compute, up from $2.0 million in the prior quarter.
  • Over five years, Revenue peaked at $3.2 million in Q4 2025 and troughed at $2.0 million in Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Amgen 206.54 Bn 192.56 Bn 7.24 Bn 10.05 Bn
2 Gilead Sciences 179.55 Bn 176.37 Bn 6.22 Bn 7.80 Bn
3 Vertex Pharmaceuticals 131.10 Bn 123.25 Bn 2.84 Bn 3.33 Bn
4 Regeneron Pharmaceuticals 81.61 Bn 73.62 Bn 3.93 Bn 4.29 Bn
5 Argenx Se 60.69 Bn 55.51 Bn 1.37 Bn 1.52 Bn
6 Moderna 53.54 Bn 48.40 Bn 52.00 Mn 145.00 Mn
7 Alnylam Pharmaceuticals 33.41 Bn 30.10 Bn 992.69 Mn 1.29 Bn
8 Biogen 31.80 Bn 30.52 Bn 1.96 Bn 2.74 Bn
9 Roivant Sciences 29.08 Bn 29.08 Bn 1.16 Mn 1.44 Mn
10 Alpha Compute 39.30 Mn 39.30 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 3.20 Mn
Dec 31, 2022 2.00 Mn
Dec 31, 2010 1.17 Mn
Sep 30, 2010 1.35 Mn
Dec 31, 2009 646,426.55
Sep 30, 2009 695,087.14
Jun 30, 2009 2,568.49
Mar 31, 2009 -123,826.01